US Patent 10662213 Gemcitabine prodrugs
Patent 10662213 was granted and assigned to NuCana on May, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 25, 2015
Date of Patent
May 26, 2020
Patent Applicant
Patent Application Number
15308491
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10662213 Gemcitabine prodrugs
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
